Zusammenfassung
Deutsche Uro-Onkologen e.V. (d-uo) verfolgen das Ziel, über die Dokumentation und
wissenschaftliche Analyse der ambulanten Versorgung urologischer Tumorerkrankungen
hinaus auch qualitätssichernde Maßnahmen sowie die Vertretung ökonomischer und sozialpolitischer
Interessen der niedergelassenen Uro-Onkolog*innen in Deutschland zu organisieren.
Nachdem das Nationale Register Urothelkarzinom (UroNAT) seit Oktober 2021 aktiv ist,
steht nun seit Oktober 2022 auch das Nationale Register Prostatakarzinom (ProNAT)
von d-uo zur Verfügung. An diesen deutschlandweit geführten Registern können alle
uro-onkologischen Behandler mitwirken, also Urolog*innen, Onkolog*innen und Krankenhäuser
über ihre Klinikambulanzen. Mit diesen Nationalen Tumorregistern wird d-uo erneut
seinem Anspruch auf profunde Datenerhebung gerecht.
Abstract
The German Society of Uro-Oncologists (“Deutsche Uro-Onkologen e.V.”, d-uo) provides
a national registry for urothelial cancer (UroNat) and a national registry for prostate
cancer (ProNAT). These registries aim to evaluate the standard of care for urothelial
cancer of the bladder and the upper urinary tract as well as prostate cancer by office-based
urologists, oncologists and outpatient hospital departments in Germany.
This includes, but is not limited to, adherence to guidelines during the treatment
of patients with urothelial cancer and prostate cancer. The registries aim to capture
and analyse scientifically how patients with these two most frequent urological tumours
are treated and how quality assurance is implemented to improve the quality of their
outpatient treatment in Germany.
Both registries may share basic patient data supplied by the non-interventional, prospective,
multicentre VERSUS registry by d-uo, which has been ongoing since 2018 and today includes
more than 15,000 patients with different urological malignancies. In the UroNAT and
ProNAT registries, additional items and parameters are included to allow for more
detailed analyses of outcomes of outpatient treatments in Germany, which have so far
been unavailable from the German Cancer Registry.
By documenting the current treatment landscape of urothelial and prostate cancer in
the outpatient setting, the registries intend to identify potential improvements of
patient care and to initiate their implementation into clinical practice. These non-interventional
prospective registries only document daily routine diagnostics, clinical courses and
procedures.
Schlüsselwörter
d-uo - ProNAT - UroNAT - Prostatakarzinom - Urothelkarzinom
Keywords
d-uo - ProNAT - UroNAT - prostate cancer - urothelial cancer
